We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Directories » FDA Approved Drugs » Effexor (venlafaxin HCL)

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Effexor (venlafaxin HCL)

  • Profile

Profile

Contact Information

Currently Enrolling Trials

    Show More

    General Information

    Effexor was approved for the treatment of depression in 1993. Effexor increases the levels of both serotonin and norepinephrine (two neurotransmitters though to cause the symptoms of depression) in the brain.

    Effexor's latest approval is for the treatment of anxiety disorder. It is estimated that 95% of people with depression experience at least one symptom of anxiety, including excessive or uncontrollable worry, apprehension, irritability, and muscle tension. Studies suggest that co-morbid depression and anxiety may have an impact on a patient's social functioning and is associated with a 30% to 60% increase in the utilization of healthcare services.

    Side Effects

    Some of the side effects of Effexor include the following:

    • headache
    • nausea
    • weight loss
    • constipation
    • blurry vision
    • diarrhea
    • dizziness
    • dry mouth
    • increased blood pressure

    Mechanism of Action

    Effexor affects various neuro chemicals in the body which are responsible for nervous system regulation. It inhibits specifically norepinephrine and serotonin reuptake, and also weakly inhibits dopamine reuptake. The net result is more neuro chemicals circulating in the nervous system.

    Additional Information

    Pregnancy and Breastfeeding Issues

    If you are pregnant, plan to become pregnant, or breastfeeding, discuss the potential risks of this or any medication with your doctor.

    It is also recommended that you talk to your doctor about Effexor if you have: high blood pressure, heart, liver, or kidney disease.

    Approval Date: 1999-03-01
    Date Created: 1999-06-16 12:00:00
    Company Name: Wyeth
    Back to Listings

    Upcoming Events

    • 16Dec

      Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

    Featured Products

    • Regenerative-medicine-steps-to-accelerate-development-pdf

      Regenerative Medicine: Steps to Accelerate Development — PDF

    • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

      Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

    Featured Stories

    • Ich_logo

      ICH Overhauls 22-Year-Old Clinical Studies Guideline

    • Survey_chart2019

      Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

    • China-360x240

      U.S. Tops List of Trial Startups With China Making Progress in Phase 1

    • Phoneapp-360x240

      Device Apps Present Unique Risks in Trials

    New!

    2019 Site Survey Reports

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 617.948.5100 – Toll free 866.219.3440

    Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing